Multiple endocrine neoplasia type 2: management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC)

MLA

B, Conte-Devolx, et al. “Multiple Endocrine Neoplasia Type 2: Management of Patients and Subjects at Risk. French Study Group on Calcitonin-Secreting Tumors (GETC).” Hormone Research, vol. 47, no. 4–6, Jan. 1997. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9f7a3dd5ecadf6f8c73b1976464e0b0f&authtype=sso&custid=ns315887.

APA

B, C.-D., I, S., P, N., B, M., A, B., N, B., J B, C., A, M., J F, H., & E, M. (1997). Multiple endocrine neoplasia type 2: management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC). Hormone Research, 47(4–6).

Chicago

B, Conte-Devolx, Schuffenecker I, Niccoli P, Maes B, Boneu A, Barbot N, Corcuff J B, Murat A, Henry J F, and Modigliani E. 1997. “Multiple Endocrine Neoplasia Type 2: Management of Patients and Subjects at Risk. French Study Group on Calcitonin-Secreting Tumors (GETC).” Hormone Research 47 (4–6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9f7a3dd5ecadf6f8c73b1976464e0b0f&authtype=sso&custid=ns315887.